News

Fund+ in the news.

source date title
Press release 5 September 2017

Immunic Therapeutics adds new investors and completes series A financing round of total EUR 31,7 Million

Press release 29 Augustus 2017

Dosing of First Patient with investigational agent OMO-1

Press release 28 July 2017

iTeos Therapeutics granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region

Press release 3 April 2017 Astellas to Acquire Ogeda SA – Acquisition Expands Astellas’ Late Stage Clinical Pipeline with Fezolinetant
Press release 19 January 2017 Octimet Oncology NV secures over EUR 11 million to develop it highly selective MET kinase inhibitors
Biotech Finances 31 October 2016 Le francophile de la semaine: Chris Buyse
European Biotechnology 28 October 2016 Belgian Fund+ raises €125  for biotech
Press release 28 October 2016 Promethera Biosciences raises eur 10 million in a series c-extension financing to advance its broad product pipeline in liver diseases
L’Echo 27 October 2016 Désiré Collen. Le scientifique qui fait fructifier les pépites.
Press release 26 October 2016 Fund+ announces eur 125 million closing of Life Sciences Impact Fund. Dr Debasish Roychowdhury appointed independent board member and Chairman of the Scientific Guidance Committee
L’Echo 19 October 2016 Fund+ prêt à investir 125 milions dans les biotechs belges.
L’Echo 19 October 2016 Après 18 mois d’activité, Fund+ est déjà le plus gros fonds biotech belge
eTheRNA 14 March 2016 eTheRNA secures EUR 24 million to develop its – TriMix mRNA-based immunotherapy
Press release 10 February 2016 Euroscreen SA appoints Dr. Philippe Monteyne and Dr. Jean-Paul Prieels to its Board of Directors
Press release 25 January 2016 Amatsigroup acquires Q-Biologicals and strenghens its offering for international pharmaceutical groups.
puurADMB December 2015 Lichtpunten in de wetenschap, Professor Désiré Collen, arts, chemicus en oprichter van ThromboGenics
De Tijd 19 December 2015 De Scheidingsmuur tussen profit en non-profit begint te barsten.
Knack 17 June 2015 Biotechnologie: de belangrijkste spelers en investeerders in Vlaanderen. Op zoek naar het supermedicijn.
L’Echo 5 June 2015 Le nouveau project du fondateur de ThromboGenics.
Trends 11 December 2014 Désiré Collen richt investeringsfonds van 100 miljoen eur op – Investeringen tegen struikroverij.


 


 


 



press release 3 April 2017

ETheRNA press release 14 March 2016

ETheRNA press release 14 March 2016

ETheRNA press release 14 March 2016

ETheRNA press release 14 March 2016

ETheRNA press release 14 March 2016

fund-press-release-english-dutch-french-incl-one-pagers-oct16-1_intro

http://www.lecho.be/entreprises/pharma_biotechnologie/Fund_pret